🔗 Permalink

Inventor profile of:

Patrick Mohr

City:

Bad Breisig

Country:

Germany

Published Applications:

25

Last publication date:

2024-11-14

Top Assignees for applications by Patrick Mohr

The entities that hold a legal rights for patent applications filed by inventor Mohr Patrick:

LTS LOHMANN THERAPIE-SYSTEME AG 15 Andernach, Germany
Gruenenthal GmbH 1 Aachen, Germany

Recent patent applications by Mohr Patrick

Patrick Mohr from Bad Breisig, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-11-14

US20240374544A1

Human necessities

TRANSDERMAL THERAPEUTIC SYSTEM FOR THE TRANSDERMAL ADMINISTRATION OF GUANFACINE COMPRISING GUANFACINE AND A MONO-CARBOXYLIC ACID

#2 | 2024-08-29

US20240285546A1

Human necessities

TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING AGOMELATINE

#3 | 2024-07-04

US20240216299A1

Human necessities

TRANSMUCOSAL THERAPEUTIC SYSTEM CONTAINING AGOMELATINE

#4 | 2022-12-22

US20220401389A1

Human necessities

TRANSMUCOSAL THERAPEUTIC SYSTEM CONTAINING AGOMELATINE

#5 | 2022-10-13

US20220323370A1

Human necessities

TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING ASENAPINE AND POLYSILOXANE OR POLYISOBUTYLENE

#6 | 2022-08-04

US20220241216A1

Human necessities

TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING AN ACTIVE AGENT-CONTAINING LAYER COMPRISING AN ACRYLIC POLYMER AND A SKIN CONTACT LAYER COMPRISING A SILICONE GEL ADHESIVE

#7 | 2022-08-04

US20220241215A1

Human necessities

TRANSDERMAL THERAPEUTIC SYSTEM COMPRISING AN ACTIVE AGENT-CONTAINING LAYER COMPRISING A SILICONE-CONTAINING POLYMER AND A SKIN CONTACT LAYER COMPRISING A SILICONE GEL ADHESIVE

#8 | 2021-10-28

US20210330601A1

Human necessities

Transdermal therapeutic system containing asenapine

#9 | 2021-09-16

US20210287764A1

SYSTEM FOR DETERMINING A SUITABILITY OF AN ACTIVE INGREDIENT TO BE APPLIED TRANSDERMALLY OR TRANSMUCOSALLY AND CORRESPONDING METHOD

#10 | 2021-08-19

US20210251916A1

Human necessities

TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING RIVASTIGMINE

#11 | 2021-08-19

US20210251915A1

Human necessities

Transdermal therapeutic system containing asenapine

#12 | 2021-08-19

US20210251914A1

Human necessities

TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING ASENAPINE

#13 | 2020-06-18

US20200188317A1

Human necessities

Transdermal therapeutic system containing asenapine

#14 | 2020-06-11

US20200179298A1

Human necessities

Transdermal therapeutic system containing asenapine and silicone acrylic hybrid polymer

#15 | 2020-03-19

US20200085759A1

Human necessities

Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutylene

#16 | 2019-11-07

US20190336454A1

Human necessities

Transdermal therapeutic system containing asenapine

#17 | 2019-10-03

US20190298662A1

Human necessities

TRANSDERMAL ADMINISTRATION OF MEMANTINE

#18 | 2019-05-09

US20190134254A1

Human necessities

Water-vapor-permeable adhesive bandages

#19 | 2018-07-12

US20180193283A1

Human necessities

TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING ASENAPINE

#20 | 2017-02-16

US20170046504A1

SYSTEM FOR DETERMINING A SUITABILITY OF AN ACTIVE INGREDIENT TO BE APPLIED TRANSDERMALLY OR TRANSMUCOSALLY AND CORRESPONDING METHOD

#21 | 2016-06-09

US20160158515A1

Human necessities

Transdermal therapeutic system with pressure generating device

#22 | 2014-08-21

US20140234395A1

Human necessities

Plaster having adjustable occlusion

#23 | 2012-05-03

US20120109033A1

Human necessities

WATER-VAPOR PERMEABLE ADHESIVE BANDAGES

#24 | 2012-03-15

US20120065599A1

Human necessities

Transdermal therapeutic system having controlled active substance flow comprising a basic reacting oxide

#25 | 2011-12-22

US20110313372A1

Human necessities

Transdermal administration of memantine

InventorID:

879276 ⎘